# Novian Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novian-health

- Industry: Medical Devices & Equipment
- Headquarters: Chicago, US
- Website: www.novianhealth.com
- Total disclosed funding: $24M
- Latest round: Series A (Jan 26, 2014)
- Investors on record: 1

## About

Novian Health Inc. is a medical technology company focused on innovative laser therapy solutions, particularly the Novilase Interstitial Laser System for minimally invasive breast tumor treatment.Novian Health Inc. specializes in laser therapy solutions, mainly through its flagship Novilase Interstitial Laser System. The company is headquartered in Chicago, US. Chip Appelbaum leads the company as CEO. In July 2021, Novian Health raised USD 1.00 mn in venture debt funding, which will be used for general working capital purposes. The company has engaged in 6 deals to date, with the latest deal occurring on July 28, 2021.Novian Health offers the Novilase Interstitial Laser System, designed to provide a minimally invasive treatment for both malignant and benign breast tumors. This procedure employs ultrasound guidance to accurately target tumors, ensuring the preservation of healthy tissue and improving patient comfort. The technology has received the CE Mark in Europe and Breakthrough Device designation from the FDA in the US, catering primarily to healthcare facilities and breast centers across North America and Europe.Novian Health generates revenue through the sale of the Novilase Interstitial Laser System and related services to medical facilities. The sales model includes direct transactions with healthcare providers who implement the Novilase technology in their treatment protocols. Revenue streams include the sale of laser systems, service contracts for maintenance and training, and post-marketing clinical follow-ups to enhance product efficacy. Pricing aligns with industry standards reflecting the specialized nature of the technology.In 2021, Novian Health plans to focus on expanding its market reach, particularly in North America and Europe. They aim to enhance product offerings and potentially launch new developments in laser therapy solutions. The recent funding of USD 1.00 mn will support these initiatives, enabling the company to strengthen its operational capabilities to better serve the medical community.

## Funding rounds

- Series A, Jan 26, 2014, $13M — iNetworks
- Series A, Feb 4, 2013, $11M — iNetworks

## Investors

- iNetworks (https://capitalatlas.ai/funds/inetworks) — Series A